Exome Asset Management LLC Dr Reddys Laboratories LTD Transaction History
Exome Asset Management LLC
- $133 Billion
- Q4 2024
A detailed history of Exome Asset Management LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Exome Asset Management LLC holds 117,500 shares of RDY stock, worth $1.59 Million. This represents 1.39% of its overall portfolio holdings.
Number of Shares
117,500
Previous 36,300
223.69%
Holding current value
$1.59 Million
Previous $2.88 Billion
35.67%
% of portfolio
1.39%
Previous 1.95%
Shares
4 transactions
Others Institutions Holding RDY
# of Institutions
264Shares Held
107MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$154 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$152 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$135 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$127 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$75.7 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.24B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...